Bio-Key®国际及时符合纳斯达克上市规则5250（1），及时提交其表格10-K，截至2024年12月31日

新泽西州霍尔姆德尔，2025年4月24日（Globe Newswire） - Bio-Key®International，Inc。Bkyi，劳动力和客户身份和访问管理（IAM）解决方案的创新提供商，具有无密码的解决方案

HOLMDEL, N.J. , April 24, 2025 (GLOBE NEWS WIRE) -- BIO-key® International, Inc. (NASDAQ:BKYI) , an innovative provider of workforce and customer Identity and Access Management (IAM) solutions featuring passwordless, phoneless and token-less Identity-Bound Biometric (IBB) authentication, announced that on April 17, 2025, it received a notification letter from The Nasdaq Stock Market, LLC informing the Company that it was not in compliance with Nasdaq Listing Rule 5250(c)(1), which requires listed companies to timely file all required periodic financial reports with the Securities and Exchange Commission, due to the Company’s failure to timely file its Annual Report on Form 10-K for the year ended December 31, 2024. The notification letter has no immediate effect on the listing or trading of the Company’s common stock on the Nasdaq Capital Market.

新泽西州霍尔姆德尔，2025年4月24日（环球新闻电线） - Bio-Key®国际公司（NASDAQ：BKYI），一家创新的劳动力和客户身份和访问管理（IAM）解决方案（iAM）的无密码，无密码，无通话，无通话，无需标识的生物识别（IBB）的启用（IBB）的宣布。股票市场，有限责任公司通知公司，不符合纳斯达克上市规则5250（c）（1），该规则要求上市公司及时向美国证券交易委员会提交所有必需的定期财务报告，该公司由于该公司未能在12月31日截至12月31日的10-K上及时提交的年度报告，该公司的股票不得不在2024年的公共销售中，该公司的年度交易是2024年的公共销售。纳斯达克资本市场。

On April 23, 2025, the Company filed its Form 10-K for the year ended December 31, 2024 with the SEC. On April 24, 2025, the Company received notice from Nasdaq stating that the Company has regained compliance with Nasdaq Listing Rule 5250(c)(1) and that the matter has been closed.

2025年4月23日，该公司在截至2024年12月31日的年度截至SEC的年度10-K。 2025年4月24日，该公司收到了纳斯达克的通知，称该公司已重新获得纳斯达克上市规则5250（c）（1）的遵守情况，并且此事已关闭。

About BIO-key International, Inc. (www.BIO-key.com)

关于Bio-Key International，Inc。（www.bio-key.com）

BIO-key is revolutionizing authentication and cybersecurity with biometric-centric, multi-factor identity and access management (IAM) software securing access for over forty million users. BIO-key allows customers to choose the right authentication factors for diverse use cases, including phoneless, tokenless, and passwordless biometric options. Its cloud-hosted or on-premise PortalGuard IAM solution provides cost-effective, easy-to-deploy, convenient, and secure access to computers, information, applications, and high-value transactions.

Bio-Key通过以生物特征识别，多因素身份和访问管理（IAM）软件（可确保超过四千万用户的访问权限）进行了革新身份验证和网络安全。 Bio-Key允许客户选择适当的身份验证因素，以用于不同的用例，包括无音机，无需密码和无密码的生物识别选项。它的云托管或本地门户网站IAM解决方案提供了对计算机，信息，应用程序和高价值交易的经济效率，易于操作，方便且安全的访问。

Engage with BIO-key

与生物钥匙互动

Investor Contact:William Jones, David CollinsCatalyst IRBKYI@catalyst-ir.comor 212-924-9800

投资者联系：William Jones，David Collinscatalyst irbkyi@catalyst-ir.comor 212-924-9800